Nevada Board of Pharmacy informational statement indicates adopted NAC 453.510 amendment adding ethylphenidate and 2‑methyl AP‑237 to Schedule I

An informational statement dated January 21, 2026 describes an adopted Nevada State Board of Pharmacy regulation amending NAC 453.510 (Schedule I) to add ethylphenidate and 2‑methyl AP‑237 (2‑MAP) to Nevada’s Schedule I in conformity with federal scheduling. This adoption signals a binding scheduling update in the Nevada administrative rulemaking process; once effective/codified per Nevada procedures, regulated entities should treat these substances as Schedule I for compliance screening, handling controls, and related controlled substance obligations applicable under Nevada law.